China Monoclonal Antibody Market (2025-2031) | Growth, Forecast, Trends, Industry, Companies, Analysis, Competitive Landscape, Segmentation, Share, Size & Revenue, Outlook, Value

Market Forecast By Source (Murine, Chimeric, Humanized, Human), By Production (In Vivo, In Vitro), By Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Others), By End use (Hospitals, Research Institutes, Others) And Competitive Landscape
Product Code: ETC6747934 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • China Monoclonal Antibody Market Outlook
  • Market Size of China Monoclonal Antibody Market, 2024
  • Forecast of China Monoclonal Antibody Market, 2031
  • Historical Data and Forecast of China Monoclonal Antibody Revenues & Volume for the Period 2021- 2031
  • China Monoclonal Antibody Market Trend Evolution
  • China Monoclonal Antibody Market Drivers and Challenges
  • China Monoclonal Antibody Price Trends
  • China Monoclonal Antibody Porter's Five Forces
  • China Monoclonal Antibody Industry Life Cycle
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Source for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Murine for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Chimeric for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Humanized for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Human for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Production for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By In Vivo for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By In Vitro for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Cancer for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Autoimmune Diseases for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Inflammatory Diseases for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Microbial Diseases for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By End use for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Research Institutes for the Period 2021- 2031
  • Historical Data and Forecast of China Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
  • China Monoclonal Antibody Import Export Trade Statistics
  • Market Opportunity Assessment By Source
  • Market Opportunity Assessment By Production
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By End use
  • China Monoclonal Antibody Top Companies Market Share
  • China Monoclonal Antibody Competitive Benchmarking By Technical and Operational Parameters
  • China Monoclonal Antibody Company Profiles
  • China Monoclonal Antibody Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the China Monoclonal Antibody Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the China Monoclonal Antibody Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 China Monoclonal Antibody Market Overview

3.1 China Country Macro Economic Indicators

3.2 China Monoclonal Antibody Market Revenues & Volume, 2021 & 2031F

3.3 China Monoclonal Antibody Market - Industry Life Cycle

3.4 China Monoclonal Antibody Market - Porter's Five Forces

3.5 China Monoclonal Antibody Market Revenues & Volume Share, By Source, 2021 & 2031F

3.6 China Monoclonal Antibody Market Revenues & Volume Share, By Production, 2021 & 2031F

3.7 China Monoclonal Antibody Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.8 China Monoclonal Antibody Market Revenues & Volume Share, By End use, 2021 & 2031F

4 China Monoclonal Antibody Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in China, driving the demand for monoclonal antibody therapies.

4.2.2 Growing investments in biotechnology and pharmaceutical research in China.

4.2.3 Favorable government initiatives and policies supporting the development and adoption of monoclonal antibodies in healthcare.

4.3 Market Restraints

4.3.1 High cost associated with monoclonal antibody therapies limiting affordability for a large section of the population.

4.3.2 Stringent regulatory requirements and approval processes for monoclonal antibodies in China.

4.3.3 Competition from biosimilars and alternative treatments affecting market growth.

5 China Monoclonal Antibody Market Trends

6 China Monoclonal Antibody Market, By Types

6.1 China Monoclonal Antibody Market, By Source

6.1.1 Overview and Analysis

6.1.2 China Monoclonal Antibody Market Revenues & Volume, By Source, 2021- 2031F

6.1.3 China Monoclonal Antibody Market Revenues & Volume, By Murine, 2021- 2031F

6.1.4 China Monoclonal Antibody Market Revenues & Volume, By Chimeric, 2021- 2031F

6.1.5 China Monoclonal Antibody Market Revenues & Volume, By Humanized, 2021- 2031F

6.1.6 China Monoclonal Antibody Market Revenues & Volume, By Human, 2021- 2031F

6.2 China Monoclonal Antibody Market, By Production

6.2.1 Overview and Analysis

6.2.2 China Monoclonal Antibody Market Revenues & Volume, By In Vivo, 2021- 2031F

6.2.3 China Monoclonal Antibody Market Revenues & Volume, By In Vitro, 2021- 2031F

6.3 China Monoclonal Antibody Market, By Indication

6.3.1 Overview and Analysis

6.3.2 China Monoclonal Antibody Market Revenues & Volume, By Cancer, 2021- 2031F

6.3.3 China Monoclonal Antibody Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F

6.3.4 China Monoclonal Antibody Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F

6.3.5 China Monoclonal Antibody Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.6 China Monoclonal Antibody Market Revenues & Volume, By Microbial Diseases, 2021- 2031F

6.3.7 China Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

6.4 China Monoclonal Antibody Market, By End use

6.4.1 Overview and Analysis

6.4.2 China Monoclonal Antibody Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 China Monoclonal Antibody Market Revenues & Volume, By Research Institutes, 2021- 2031F

6.4.4 China Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

7 China Monoclonal Antibody Market Import-Export Trade Statistics

7.1 China Monoclonal Antibody Market Export to Major Countries

7.2 China Monoclonal Antibody Market Imports from Major Countries

8 China Monoclonal Antibody Market Key Performance Indicators

8.1 Number of new clinical trials for monoclonal antibodies initiated in China.

8.2 Research and development expenditure by biopharmaceutical companies on monoclonal antibody projects in China.

8.3 Number of partnerships and collaborations between domestic and international companies for monoclonal antibody development in China.

9 China Monoclonal Antibody Market - Opportunity Assessment

9.1 China Monoclonal Antibody Market Opportunity Assessment, By Source, 2021 & 2031F

9.2 China Monoclonal Antibody Market Opportunity Assessment, By Production, 2021 & 2031F

9.3 China Monoclonal Antibody Market Opportunity Assessment, By Indication, 2021 & 2031F

9.4 China Monoclonal Antibody Market Opportunity Assessment, By End use, 2021 & 2031F

10 China Monoclonal Antibody Market - Competitive Landscape

10.1 China Monoclonal Antibody Market Revenue Share, By Companies, 2024

10.2 China Monoclonal Antibody Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence